Join
Live feed
·
PRReleasevia Quantisnow
Pacira BioSciences Inc. logo

Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases

ByQuantisnow·Wall Street's wire, on your screen.
PCRX· Pacira BioSciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PCRX (Pacira BioSciences Inc.) and more on Quantisnow.